Literature DB >> 26543628

Etomidate: to use or not to use for endotracheal intubation in the critically ill?

Nathan J Smischney1, Rahul Kashyap1, Ognjen Gajic1.   

Abstract

Endotracheal intubation is frequently performed in the intensive care unit (ICU). It can be life-saving for many patients who present with acute respiratory distress. However, it is equally associated with complications that may lead to unwanted effects in this patient population. According to the literature, the rate of complications associated with endotracheal intubation is much higher in an environment such as the ICU as compared to other, more controlled environments (i.e., operating room). Thus, the conduct of performing such a procedure needs to be accomplished with the utmost care. To facilitate establishment of the breathing tube, sedation is routinely administered. Given the tenuous hemodynamic status of the critically ill, etomidate was frequently chosen to blunt further decreases in blood pressure and/or heart rate. Recently however, reports have demonstrated a possible association with the use of etomidate for endotracheal intubation and mortality in the critically ill. In addition, this association seems to be predominantly in patients diagnosed with sepsis. As a result, some have advocated against the use of this medication in septic patients. Due to the negative associations identified with etomidate and mortality, several investigators have evaluated potential alternatives to this solution (e.g., ketamine and ketamine-propofol admixture). These studies have shown promise. However, despite the evidence against using etomidate for endotracheal intubation, other studies have demonstrated no such association. This leaves the critical care clinician with uncertainty regarding the best sedative to administer in this patient population. The following editorial discusses current evidence regarding etomidate use for endotracheal intubation and mortality. In particular, we highlight a recent article with the largest population to date that found no association between etomidate and mortality in the critically ill and illustrate important findings that the reader should be aware of regarding this article.

Entities:  

Keywords:  Endotracheal intubation; etomidate; intensive care unit (ICU); mortality; sepsis

Year:  2015        PMID: 26543628      PMCID: PMC4598512          DOI: 10.3978/j.issn.2072-1439.2015.09.08

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  18 in total

1.  Etomidate and fatal outcome--even a single bolus dose may be detrimental for some patients.

Authors:  R Bloomfield; D W Noble
Journal:  Br J Anaesth       Date:  2006-07       Impact factor: 9.166

2.  Tracheal intubation in the critically ill: a multi-centre national study of practice and complications.

Authors:  G D Simpson; M J Ross; D W McKeown; D C Ray
Journal:  Br J Anaesth       Date:  2012-02-06       Impact factor: 9.166

3.  Complications of endotracheal intubation in the critically ill.

Authors:  Donald E G Griesdale; T Laine Bosma; Tobias Kurth; George Isac; Dean R Chittock
Journal:  Intensive Care Med       Date:  2008-07-05       Impact factor: 17.440

Review 4.  The effect of etomidate on adrenal function in critical illness: a systematic review.

Authors:  Stewart G Albert; Srividya Ariyan; Ayesha Rather
Journal:  Intensive Care Med       Date:  2011-03-04       Impact factor: 17.440

Review 5.  Single-dose etomidate does not increase mortality in patients with sepsis: a systematic review and meta-analysis of randomized controlled trials and observational studies.

Authors:  Wan-Jie Gu; Fei Wang; Lu Tang; Jing-Chen Liu
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

6.  Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery.

Authors:  Ryu Komatsu; Jing You; Edward J Mascha; Daniel I Sessler; Yusuke Kasuya; Alparslan Turan
Journal:  Anesth Analg       Date:  2013-12       Impact factor: 5.108

7.  A comparison of the effects of etomidate and midazolam on hospital length of stay in patients with suspected sepsis: a prospective, randomized study.

Authors:  Karis L Tekwani; Hannah F Watts; Rolla T Sweis; Kathleen H Rzechula; Erik B Kulstad
Journal:  Ann Emerg Med       Date:  2010-09-15       Impact factor: 5.721

8.  Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial.

Authors:  Patricia Jabre; Xavier Combes; Frederic Lapostolle; Mohamed Dhaouadi; Agnes Ricard-Hibon; Benoit Vivien; Lionel Bertrand; Alexandra Beltramini; Pascale Gamand; Stephane Albizzati; Deborah Perdrizet; Gaelle Lebail; Charlotte Chollet-Xemard; Virginie Maxime; Christian Brun-Buisson; Jean-Yves Lefrant; Pierre-Edouard Bollaert; Bruno Megarbane; Jean-Damien Ricard; Nadia Anguel; Eric Vicaut; Frederic Adnet
Journal:  Lancet       Date:  2009-07-01       Impact factor: 79.321

Review 9.  Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.

Authors:  Eric A Bruder; Ian M Ball; Stacy Ridi; William Pickett; Corinne Hohl
Journal:  Cochrane Database Syst Rev       Date:  2015-01-08

10.  Etomidate for anesthesia induction: friends or foe in major cardiac surgery?

Authors:  Audrey De Jong; Samir Jaber
Journal:  Crit Care       Date:  2014-10-10       Impact factor: 9.097

View more
  1 in total

1.  ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats.

Authors:  Bin Wang; Shouming Chen; Jun Yang; Linghui Yang; Jin Liu; Wensheng Zhang
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.